Total buying$00 buys
CYTK
CYTOKINETICS INC
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$1.41M4 sells
Net open-market−$1.41MBuying minus selling
Active insiders2Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 13, 2026
Open-market transaction mix · 4 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 2 | 0 | $0 | $729k | -$729k |
| Oct 2026 | 0 | 2 | 0 | $0 | $686k | -$686k |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (2)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- BI-$803.5k
- MI-$399.2k
CYTK transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period12transactionstxns
- M · Option exercise · dominant8 · 67%
- S · Open-market sells4 · 33%
Activity by reported role
A joint filing can contribute to multiple rolesChief executive officer6
ER6
PRES6
Reported Holdings After
Separated by insider, security, and ownership type
Malik Fady IbrahamCommon Stock · Direct
153,902Oct 06, 2026
Blum Robert ICommon Stock · Direct
278,544Oct 12, 2026
Malik Fady IbrahamNon-Qualified Stock Option (Right to Buy) · Direct
19,886Oct 06, 2026
Blum Robert INon-Qualified Stock Option (Right to Buy) · Direct
141,745Oct 12, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
CYTOKINETICS INC Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at CYTOKINETICS INC?
Blum Robert I, Malik Fady Ibraham.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Blum Robert I reported a sale on Oct 12, 2026 valued at $471k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $1,416,395.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.